| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786942 | European Journal of Surgical Oncology (EJSO) | 2018 | 6 Pages |
Abstract
To our knowledge, in this study for the first time MR feasibility after Sienna injection was investigated. Sienna+® impaired breast MRI after a mean follow-up time of 42 months in half of the cases. Further research is needed to investigate time and field-strength dependency of tracer detectability as well as the diagnostic impact of these artifacts on contrast-enhanced imaging in a clinical setting.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Benedict Krischer, Serafino Forte, Tilo Niemann, Rahel A. Kubik-Huch, Cornelia Leo,